Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
PROPAFENONE HYDROCHLORIDE EXTENDED RELEASE CAPSULES
Medication labelWhy this: Advisory · dailymed-prescription
Propafenone Extended Release Capsules are indicated to prolong the time to recurrence of symptomatic atrial fibrillation in patients without structural heart disease. The use of propafenone ER capsules in patients with permanent atrial fibrillation or in patients exclusively with atrial flutter or PSVT has not been evaluated. Propafenone ER capsules should not be used to control ventricular rate during atrial fibrillation. The effect of propafenone ER capsules on mortality has not been determined (see black box WARNINGS).
- generic_name
- propafenone hydrochloride
- product_names
- propafenone hydrochloride
- ndc
- 21695-814, 49884-210, 21695-814-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en